3D Printed heart valves to be commercialised
By Richard Schoonraad | Biomedical engineering, Cardiovascular Disease, Cardiovascular Disease, Heart, Media Releases, News & Events, T3mPLATE Laboratory, Vascular EngineeringCutting-edge biopolymer 3D-printed heart valve technology to be commercialised in Australia to help millions globally suffering from aortic stenosis. CUREator, Australia’s national biotech incubator, funds Western Australian biomedical engineering and…
Antibiotics resistance solution to be commercialised
By Richard Schoonraad | Bacteria, Cardiovascular Science and Diabetes Program, Emergency Medicine, Kidney Disease, Media Releases, News & Events, Synthetic Biology and Drug Discovery, Targeted Drug Delivery, TranslationBreakthrough diagnostic technology to be commercialised in Australia in race to save millions globally from antibiotic resistant sepsis. CUREator funds Western Australian research team to develop life-saving technology through the…

Further mysteries of cardiovascular disease-causing plaque revealed
By Richard Schoonraad | Blood Vessels, Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Heart, Media Releases, News & Events, ResearchNew discoveries on where plaque can form and what can trigger a heart attack. Researchers from the Harry Perkins Institute of Medical Research have published new findings that turn the…
Perth MedTech firm secures funding for cannula innovation
By Richard Schoonraad | Bioimaging Research and Innovation for Translational Engingeering BRITE, Funding, Imaging and Therapy, Media Releases, News & EventsVeinTech awarded $493,489 of Accelerating Commercialisation funding Perth based medical device company VeinTech is excited to announce it has secured $493,489 of matched non-dilutive funding to continue its efforts to…
New liver cancer blood test gets $2.5m research funding boost
By Richard Schoonraad | Bioimaging Research and Innovation for Translational Engingeering BRITE, Cancer, Cancer, Cancer Epigenetics, Cell Signalling, Cell-To-Cell Communication, Functional Genomics, Genes, Media Releases, News & Events, Single CellPredicting relapse for one of the world's deadliest cancers. Perth cancer researchers are on track to improve the outcomes of patients with the most common type of primary liver cancer.…
ACRF Centre for Advanced Cancer Genomics opens in Perth
By Richard Schoonraad | Bioimaging Research and Innovation for Translational Engingeering BRITE, Cancer, Cancer, Cancer Epigenetics, Cell Signalling, Cell-To-Cell Communication, Functional Genomics, Genes, Media Releases, News & Events, Single CellLatest technology analyses WA cancer patient tumours. The Australian Cancer Research Foundation (ACRF) Centre for Advanced Cancer Genomics, housing the next generation DNA sequencing technology, was opened today at the…
Reasons for hope this festive season
By Richard Schoonraad | Bioimaging Research and Innovation for Translational Engingeering BRITE, Brain, Cancer, Inspiration, Melonoma, News & EventsProf Peter Leedman AO, Director of the Harry Perkins Institute of Medical Research, provided the following end-of-year observations about the outlook for medical research in WA to The West Australian,…
New gene discovery published in New England Journal of Medicine
By Richard Schoonraad | Epigenetics and Genomics Laboratory, Genetic Disease, Genetic Disease, Genetics, News & Events, ResearchDisease-causing genetic mutation finding to impact thousands of patients world-wide The genetic cause of a brain disease that leads to vertigo, speech difficulties and loss of coordination, and which can…